LOWER RESPIRATORY TRACT INFECTIONS - PowerPoint PPT Presentation

1 / 50
About This Presentation
Title:

LOWER RESPIRATORY TRACT INFECTIONS

Description:

LOWER RESPIRATORY TRACT INFECTIONS Prof T Rogers PNEUMONIA THE IMPORTANCE OF PNEUMONIA A major killer in both developed and developing countries Accounts for more ... – PowerPoint PPT presentation

Number of Views:2144
Avg rating:3.0/5.0
Slides: 51
Provided by: TCDU2
Category:

less

Transcript and Presenter's Notes

Title: LOWER RESPIRATORY TRACT INFECTIONS


1
LOWER RESPIRATORY TRACT INFECTIONS
  • Prof T Rogers

2
PNEUMONIA
3
THE IMPORTANCE OF PNEUMONIA
  • A major killer in both developed and developing
    countries
  • Accounts for more deaths than other infectious
    diseases
  • Mortality rates vary but can be as high as 25
  • A major cause of death in children in developing
    countries
  • Incidence here (?) 2-5/1000 population

4
PNEUMONIA
  • Neither radiological or microbiological criteria
    are specific for predicting the cause of
    pneumonia
  • A better approach is to first consider the
    clinical circumstances under which pneumonia
    acquired
  • Add the clinical background of the particular
    patient

5
Classification of pneumonia
  • Community-acquired
  • Hospital-acquired
  • Aspiration and anaerobic
  • Pneumonia in immunocompromised
  • AIDS-related
  • Geographically restricted
  • Recurrent

6
COMMUNITY-ACQUIRED PNEUMONIA INTRODUCTORY POINTS
  • More common at the extremes of age
  • Twice as common in winter months
  • A General Practitioner is likely to see up to 10
    cases per yr
  • Represent lt10 of all respiratory infection cases
    prescribed antibiotics
  • Most will be managed in the community

7
TYPES OF COMMUNITY ACQUIRED PNEUMONIA
  • In a previously healthy individual
  • Here the infection may have been acquired by
    droplet spread from another
  • Alternatively, in patients with underlying
    diseases endogenous colonizing bacteria may be
    the cause
  • These are more likely to be resistant to
    first-line antibiotics

8
SYMPTOMS OF PATIENTS WITH COMMUNITY-ACQUIRED
PNEUMONIA()Mc Farlane unpublished
  • Cough 92
  • Fever 86
  • Breathlessness 67
  • Pleural pain 62
  • Headache 55
  • New sputum production 54
  • Muscle aches 44
  • Nausea/vomiting 48

9
COMMUNITY ACQUIRED PNEUMONIA WHATS CAUSING IT?
10
MICROBIOLOGICAL CAUSES () OF COMMUNITY ACQUIRED
PNEUMONIA FROM HOSPITAL BASED STUDIES (N3,000)
  • CAP Severe CAP
  • No cause found 36 33
  • Pneumococcus 25 27
  • Influenza virus 8 2.3
  • Legionella spp. 7 17
  • Haem. Influenzae 5 5
  • Other viruses 5 8
  • Psittacosis/Q fever 3 2
  • Gram neg. bacilli 2.7 2
  • Staph aureus 2 5

11
INVESTIGATIONS FOR DIAGNOSIS OF PNEUMONIA
  • Non-invasive blood count, urea, albumin,LFTs,
    sputum gram, chest X-ray, CT scan
  • Culture of sputum, blood, pleural fluid
  • Serology pneumococcal, Legionella antigen
  • Invasive induced sputum, bronchoscopy, open lung
    biopsy

12
TYPICAL GRAM APPEARANCE OF Strep pneumoniae IN
SPUTUM
GRAM POSITIVE CHAINS DIPLOCOCCI
13
Streptococcus pneumoniae (pneumococcus)
  • A gram positive coccus that grows in short chains
  • Alpha haemolytic on blood agar
  • Identified by its susceptibility to optochin
  • Polysaccharide capsule confers pathogenicity-at
    least 80 serotypes
  • There are multivalent vaccines for prevention of
    pneumococcal disease

14
SOME COMPLICATIONS OF PNEUMOCOCCAL SEPSIS
  • Bacteraemia (10)
  • Empyema (1)
  • Meningitis (lt0.5)
  • Mortality rates of 10-25
  • Splenectomy or asplenia a major risk factor

15
Pneumococcal vaccine is recommended for
  • Age gt65 years
  • Underlying chronic lung disease
  • Asplenia
  • Alcoholism
  • Diabetes mellitus
  • Chronic renal failure
  • HIV infection

16
BTS Guidelinesfor the Management of Community
Acquired Pneumonia in Adults Updated 2004
  • www.brit-thoracic.org/guidelines

17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
Treatment
  • Home treated-Amoxicillin 500mg or 1 g tds PO (or
    admitted for social reasons)
  • Hospital treated Amoxicillin 500mg or 1 g PO plus
    erythromycin 500mg qds po
  • Hospital treated severe Co-amoxiclav 1.2 g tds
    and erythromycin 500mg qds I/v , /- rifampicin

21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
VIRUSES THAT CAUSE COMMUNTIY ACQUIRED PNEUMONIA
25
INFLUENZA
26
OTHER VIRAL CAUSES
  • Respiratory syncytial virus (RSV)
  • Parainfluenza viruses
  • Enteroviruses
  • (Cytomegalovirus)

27
CAUSES OF ATYPICAL PNEUMONIA
  • Mycoplasma pneumoniae
  • Chlamydia pneumoniae
  • Legionella pneumophila
  • Coxiella burnetii

28
Mycoplasma pneumoniae
  • Has no cell wall, therefore doesnt respond to
    beta lactams
  • Causes atypical pneumonia in adolescents and
    young adults
  • Dry hacking cough, low grade fever, headache
    feature
  • Isolation by culture of the organism is difficult
    therefore diagnosis is confirmed by a high CFT or
    rising titre of specific antibodies
  • Cold agglutinins also typical
  • Macrolides or tetracyclines most active

29
Chlamydia pneumoniae
  • An obligate intracellular bacterium
  • Causes mild pneumonia but may cause protracted
    symptoms
  • Sore throat, hoarseness, URT symptoms feature
  • Serological diagnosis rather than culture
  • Tetracyclines, macrolides, quinolones active

30
Legionnaires disease
  • A severe pneumonia due to Legionella pneumophila
  • Can be community or hospital acquired
  • Organism is acquired from environmental sources
    eg, humidified air conditioning, showers
  • Usually attacks debilitated individuals

31
RISK FACTORS
  • Male sex
  • Advanced age
  • Cigarette smokers
  • Alcoholism
  • Chronic lung disease
  • Immmunosuppression, malignancy

32
Legionnaires disease
  • Hyponatremia, confusion, nausea, vomiting,
    abnormal LFTs a feature
  • Diagnosis often confirmed by urinary antigen test
    (specific for serogroup 1)
  • Can be cultured on special media
  • Must be notified to Public Health as it can cause
    outbreaks
  • Most active antibiotics are macrolides,
    quinolones, rifampicin

33
Antibiotic Treatment of Community Acquired
Pneumonia
  • The priority is to cover pneumococcus
  • Penicillin, amoxycillin, cephalosporins, new
    quinolones and macrolides have all been used as
    monotherapy
  • Choice will be influenced by local resistance
    rates for pneumococcus

34
Examples of antibiotics for CAI
  • Benzylpenicillin
  • Penicillin V
  • Ampicillin, amoxycillin, Augmentin
  • Cefuroxime, cefotaxime, ceftriaxone
  • Moxifloxacin (a quinolone)
  • Erythromycin, clarythromycin, azithromycin

35
PATHOGEN PREFERRED THERAPY S pneumoniae
amoxicillin 500 mg 1.0 ga tds po or
benzylpenicillin 1.2 g qds iv M pneumoniae C
pneumoniae erythromycin 500 mg qds po or iv
or clarithromycin 500 mg bd po or iv C psittaci/C
burnetii tetracycline 250 mg 500 mg qds po
or 500 mg bd iv Legionella spp. clarithromycin
500 mg bd po or iv rifampicin c 600 mg od or
bd, po/ iv
36
Hinfluenzae Non- B-lactamase-producing
amoxicillin 500 mg tds po or ampicillin 500 mg
qds iv B-lactamase-producing co-amoxiclav 625 mg
tds po or 1.2 gtds iv Gram negative enteric
bacilli cefuroxime 1.5 g tds or cefotaxime 1-2g
tds iv or ceftriaxone 2g od iv (Comment the
table in the 2001 version incorrectly stated
bd) P.aeruginosa ceftazidime 2g tds iv plus
gentamicin or tobramycin (dose monitoring) S.aureu
s Non-MRSA flucloxacillin 1-2gqds iv rifampicin
600 mg od or bd, po/iv MRSA vancomycin 1gbd iv
(dose monitoring)
37
ACID ALCOHOL FAST RODS SUGGESTING TUBERCULOSIS
38
KLEBSIELLA PNEUMONIA (RARE)
39
COMMUNITY ACQUIRED PNEUMONIA IN INFANTS AND
CHILDREN
  • Group B streptococcus and E coli cause pneumonia
    in neonates
  • RSV an important pathogen in infants
  • Bordetella pertussis (cause of whooping cough)
    important in young children
  • As is Haemophilus influenzae type b

40
(No Transcript)
41
SOME FEATURES OF NOSOCOMIAL PNEUMONIA
  • Often ventilator associated, therefore seen in
    ITU most commonly
  • Due to both endogenous organisms and others
    acquired by cross infection
  • MRSA, gram negatives predominate
  • High associated mortality because of co-morbidity
    and antibiotic resistance

42
HOSPITAL ACQUIRED PNEUMONIA Pseudomonas
aeruginosa
43
TREATMENT OF HOSPITAL ACQUIRED PNEUMONIA
  • Will depend on the local epidemiology of the
    unit/hospital
  • Often require good cover for MRSA and gram
    negative enterobacteria
  • Therefore vancomycin and carbapenem or Tazocin
    may be used

44
PNEUMONIA IN THE IMMUNOCOMPROMISED HOST
  • Cause depends on the underlying immunodeficiency
  • More likely to present as a diffuse interstitial
    pneumonia
  • Treatment often empirical as establishing the
    cause is often difficult

45
MAJOR CAUSES OF PNEUMONIA IN IMMUNOCOMPROMISED
  • Pneumocystis jiroveci (carinii)
  • Cytomegalovirus
  • Other respiratory viruses
  • Tuberculosis
  • Fungi

46
Pneumocystis jiroveci(Lung biopsy)
Cyst stage
47
NOCARDIOSIS(Cause Nocardia asteroides, acid
fast rod)
48
Geographically restricted pneumonias
  • Typhoid
  • Melioidosis
  • Brucellosis
  • Endemic mycoses histoplasmosis
  • Helminthic paragonimiasis

49
Recurrent pneumonia
  • May be caused by local bronchial or pulmonary
    abnormality
  • Obstruction due to eg, foreign body, carcinoma,
    lymph node
  • Chronic obstructive lung disease bronchiectasis
  • Neurological disorders motor neurone disease
  • Structural tracheo-oesophageal fistula
  • Aspiration (alcoholics) anaerobic organisms
  • Immunodeficiency state hypogammaglobulinaemia

50
EMPYEMA
  • May arise as an acute complication of pneumonia
  • Characterised by collection in pleural cavity,
    malaise, fever, pleuritic pain, leucocytosis
  • Chronic empyema usually occurs after failure to
    diagnose or treat adequately an acute empyema
  • May be loculated, or associated with a
    broncho-pleural fistula
  • Organisms are those causing the original
    pneumonia, or anaerobes
  • Treat by drainage of the collection and
    antibiotics after microbiological findings
Write a Comment
User Comments (0)
About PowerShow.com